Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Cotrimoxazole/pyrazinamide

Drug-induced liver injury: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Acosta C, et al. Evaluation of Drug-induced Liver Injury in Patients Receiving Anti-tuberculosis Medications and Subsequent Management. Open Forum Infectious Diseases 9 (Suppl. 2): S620 abstr. 1431, Dec 2022. Available from: URL: http://doi.org/10.1093/ofid/ofac492.1260 [abstract] Acosta C, et al. Evaluation of Drug-induced Liver Injury in Patients Receiving Anti-tuberculosis Medications and Subsequent Management. Open Forum Infectious Diseases 9 (Suppl. 2): S620 abstr. 1431, Dec 2022. Available from: URL: http://​doi.​org/​10.​1093/​ofid/​ofac492.​1260 [abstract]
Metadaten
Titel
Cotrimoxazole/pyrazinamide
Drug-induced liver injury: case report
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33118-1

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Vancomycin

Case report

Empagliflozin

Case report

Insulin